Previous close | 0.8208 |
Open | 0.8293 |
Bid | 0.8128 x 300 |
Ask | 0.8484 x 300 |
Day's range | 0.8000 - 0.8555 |
52-week range | 0.4530 - 1.8800 |
Volume | |
Avg. volume | 1,301,243 |
Market cap | 184.977M |
Beta (5Y monthly) | 1.74 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.1800 |
Earnings date | 07 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 5.72 |
In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]
SAN DIEGO, March 12, 2024--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced the appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors. Dr. Nathan is Medical Director of Inova’s Advanced Lung Disease Program and Lung Transplant
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?